Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FONAR Co. stock logo
FONR
FONAR
$14.37
-0.9%
$12.95
$12.00
$18.68
$89.14M116,979 shs2,000 shs
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$1.87
-1.7%
$1.43
$0.87
$7.05
$91.44M0.1309,422 shs69,654 shs
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
$2.69
+0.7%
$2.26
$0.82
$3.38
$97.86M1.152.30 million shs734,383 shs
OSR Holdings, Inc. stock logo
OSRH
OSR
$1.29
-1.4%
$1.43
$1.02
$13.40
$24.90M1.542.89 million shs35,501 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FONAR Co. stock logo
FONR
FONAR
+0.69%+2.62%+17.79%0.00%-6.99%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-1.55%+5.56%+20.25%+26.67%-71.81%
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
+3.49%+0.38%+11.72%+96.32%+167.00%
OSR Holdings, Inc. stock logo
OSRH
OSR
-2.89%+12.93%-7.09%-42.54%+130,999,900.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FONAR Co. stock logo
FONR
FONAR
2.3337 of 5 stars
0.05.00.00.03.00.81.9
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
1.504 of 5 stars
3.50.00.00.02.71.70.0
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2.1179 of 5 stars
3.52.00.00.03.50.00.6
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FONAR Co. stock logo
FONR
FONAR
0.00
N/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
3.00
Buy$11.00489.21% Upside
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
3.00
Buy$9.00234.57% Upside
OSR Holdings, Inc. stock logo
OSRH
OSR
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest OSRH, GUTS, MBOT, and FONR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$12.00
4/10/2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$9.00 ➝ $9.00
(Data available from 6/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FONAR Co. stock logo
FONR
FONAR
$103.02M0.87$3.01 per share4.78$25.62 per share0.56
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
$60K1,523.92N/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/A$0.38 per shareN/A
OSR Holdings, Inc. stock logo
OSRH
OSR
-$148.95K-167.15N/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FONAR Co. stock logo
FONR
FONAR
$10.57M$1.2512.50N/A7.68%4.94%3.70%N/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$77.09M-$1.85N/AN/AN/A-64,849.48%N/A-57.21%8/13/2025 (Estimated)
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$10.74M-$0.65N/AN/AN/AN/A-218.30%-158.17%8/13/2025 (Estimated)
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/A0.00N/AN/AN/AN/AN/A

Latest OSRH, GUTS, MBOT, and FONR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/21/2025Q1 2025
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.15-$0.08+$0.07-$0.08N/AN/A
5/20/2025Q1 2025
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A-$1.04N/A-$1.04N/A$0.76 million
5/15/2025Q3 2025
FONAR Co. stock logo
FONR
FONAR
N/A$0.37N/A$0.37N/AN/A
5/13/2025Q1 2025
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.49-$0.49N/A-$0.49N/AN/A
3/26/2025Q4 2024
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
-$0.18-$0.20-$0.02-$0.20N/AN/A
3/3/2025Q4 2024
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
-$0.44-$0.52-$0.08-$0.52N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FONAR Co. stock logo
FONR
FONAR
N/AN/AN/AN/AN/A
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/AN/AN/AN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/AN/AN/AN/AN/A
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
FONAR Co. stock logo
FONR
FONAR
N/A
11.24
9.45
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
0.60
5.58
5.57
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
N/A
3.64
3.64
OSR Holdings, Inc. stock logo
OSRH
OSR
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
FONAR Co. stock logo
FONR
FONAR
50.64%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
16.30%
OSR Holdings, Inc. stock logo
OSRH
OSR
55.30%

Insider Ownership

CompanyInsider Ownership
FONAR Co. stock logo
FONR
FONAR
1.55%
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
N/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
4.74%
OSR Holdings, Inc. stock logo
OSRH
OSR
33.67%
CompanyEmployeesShares OutstandingFree FloatOptionable
FONAR Co. stock logo
FONR
FONAR
4806.20 million6.19 millionNot Optionable
Fractyl Health, Inc. stock logo
GUTS
Fractyl Health
10248.98 millionN/AN/A
Microbot Medical Inc. stock logo
MBOT
Microbot Medical
2036.38 million25.64 millionOptionable
OSR Holdings, Inc. stock logo
OSRH
OSR
N/A19.28 million2.68 millionN/A

Recent News About These Companies

OSR Holdings Inc OSRH

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
FONAR stock logo

FONAR NASDAQ:FONR

$14.37 -0.13 (-0.90%)
As of 12:10 PM Eastern

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Fractyl Health stock logo

Fractyl Health NASDAQ:GUTS

$1.87 -0.03 (-1.74%)
As of 12:38 PM Eastern

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Microbot Medical stock logo

Microbot Medical NASDAQ:MBOT

$2.69 +0.02 (+0.75%)
As of 12:40 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

OSR stock logo

OSR NASDAQ:OSRH

$1.29 -0.02 (-1.40%)
As of 12:30 PM Eastern

OSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea.